{"altmetric_id":19529354,"counts":{"readers":{"mendeley":3,"citeulike":0,"connotea":0},"total":{"posts_count":87},"news":{"unique_users_count":6,"unique_users":["2_minute_medicine","physicians_briefing","medscape","medicalxpress","doctors_lounge","medical_economics"],"posts_count":17},"twitter":{"unique_users_count":51,"unique_users":["FranciscoMarty_","kdahal57","Duke_GI_","greg_folkers","steveschoi","AnnWoolleyMD","DrDeborahFisher","mtnhealthcare","JediPD","Tr0ttaFra","SFManchaC","tomheston","lfustersanjurjo","hivguidelines","EricSALATprof","SandraKoprivnik","AnnalsofIM","mecdarling","jjcrazydiamond","jlechortiz","SorayaCastroLL","DrJHK","Relicena","pharmacovig","PotardDechaine","holly_pASTRIX","carpe_diem0820","kadsho","h_mikihiro","wataru20080712","nakatsu28","RIQuartette","takashtoy","kawalle","raspberrymxtxax","ruruuuuwn","GarbineLizeaga","rubenroa","JooCastillo","ARAdultImmDoc","KLevittMDMPH","its_only_r_n_r","SilviaPorto88","OlallaJulian","clairepomeroy","ESOTtransplant","JHepatology","marian_berrospe","LZacchilli","VersantisAG","OysterHC"],"posts_count":65},"facebook":{"unique_users_count":5,"unique_users":["247598615295951","341958175909","130767083627618","139259651470","549025681868970"],"posts_count":5}},"selected_quotes":["Important safety concerns when using DAAs in patients with #HCV who are co-infected with hepatitis B.","HBV-R Associated With DAA Therapy for Chronic HCV Annals of Internal Medicine American College of Physicians","#HCV is the leading cause of cirrhosis, hepatocellular carcinoma, and liver transplantation in the #UnitedStates","#HepatitisB Virus Reactivation Associated With #DirectActingAntiviralTherapy for Chronic #HepatitisCVirus","HBV reactivation in #HBV infected patients who get #HCV antiviral treatment with new #DAA regimens @AnnalsofIM."],"citation":{"abstract":"Direct-acting antiviral agents (DAAs) are used increasingly to treat hepatitis C virus (HCV) infection. Reports were published recently on hepatitis B virus (HBV) reactivation (HBV-R) in patients with HBV-HCV co-infection. Hepatitis B virus reactivation, defined as an abrupt increase in HBV replication in patients with inactive or resolved HBV infection, may result in clinically significant hepatitis.\nTo assess whether HBV-R is a safety concern in patients receiving HCV DAAs.\nDescriptive case series.\nU.S. Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS).\n29 patients with HBV-R receiving HCV DAAs.\nClinical and laboratory data.\nThe FDA identified 29 unique reports of HBV-R in patients receiving DAAs from 22 November 2013 to 15 October 2016. Two cases resulted in death and 1 case in liver transplantation. Patients in whom HBV-R developed were heterogeneous regarding HCV genotype, DAAs received, and baseline HBV chacteristics. At baseline, 9 patients had a detectable HBV viral load, 7 had positive results on hepatitis B surface antigen (HBsAg) testing and had an undetectable HBV viral load, and 3 had negative results on HBsAg testing and had an undetectable HBV viral load. For the remaining 10 patients, data points were not reported or the data were uninterpretable. Despite provider knowledge of baseline HBV, HBV-R diagnosis and treatment were delayed in 7 cases and possibly 7 others.\nThe quality of information varied among reports. Because reporting is voluntary, HBV-R associated with DAAs likely is underreported.\nHepatitis B virus reactivation is a newly identified safety concern in patients with HBV-HCV co-infection treated with DAAs. Patients with a history of HBV require clinical monitoring while receiving DAA therapy. Studies would help determine the risk factors for HBV-R, define monitoring frequency, and identify patients who may benefit from HBV prophylaxis and treatment. DAAs remain a safe and highly effective treatment for the management of HCV infection.\nNone.","altmetric_jid":"4f6fa4e83cf058f61000227a","authors":["Susan J. Bersoff-Matcha","Kelly Cao","Mihaela Jason","Adebola Ajao","S. Christopher Jones","Tamra Meyer","Allen Brinker","Bersoff-Matcha, Susan J.","Cao, Kelly","Jason, Mihaela","Ajao, Adebola","Jones, S. Christopher","Meyer, Tamra","Brinker, Allen"],"doi":"10.7326\/m17-0377","first_seen_on":"2017-04-24T21:46:28+00:00","funders":["niehs"],"issns":["0003-4819","1539-3704"],"journal":"Annals of Internal Medicine","last_mentioned_on":1498089678,"links":["http:\/\/annals.org\/aim\/article\/2623165\/hepatitis-b-virus-reactivation-associated-direct-acting-antiviral-therapy-chronic#.WP5xN0W6Xlw.twitter","http:\/\/annals.org\/aim\/article\/2623165\/hepatitis-b-virus-reactivation-associated-direct-acting-antiviral-therapy-chronic#.WP6Tnvs39Uw.twitter","http:\/\/annals.org\/aim\/article\/2623165\/hepatitis-b-virus-reactivation-associated-direct-acting-antiviral-therapy-chronic","http:\/\/annals.org\/aim\/article\/doi\/10.7326\/M17-0377","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28437794?dopt=Abstract","http:\/\/annals.org\/aim\/article\/2623165\/hepatitis-b-virus-reactivation-associated-direct-acting-antiviral-therapy-chronic#.WP9uqp_7OFA.twitter","http:\/\/annals.org\/aim\/article\/2623165\/hepatitis-b-virus-reactivation-associated-direct-acting-antiviral-therapy-chronic#.WP-r_9ZLCjM.twitter","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28437794?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter","http:\/\/annals.org\/aim\/article\/2623165\/hepatitis-b-virus-reactivation-associated-direct-acting-antiviral-therapy-chronic#.WQCk3I1uulc.twitter","http:\/\/annals.org\/aim\/article\/2623165\/hepatitis-b-virus-reactivation-associated-direct-acting-antiviral-therapy-chronic#.WQDwJD2CMBw.twitter","http:\/\/dx.doi.org\/10.7326\/M17-0377","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28437794?dopt=Abstract&utm_source=dlvr.it&utm_medium=facebook"],"pdf_url":"http:\/\/annals.org\/data\/journals\/aim\/0\/aime201706200-m170377.pdf","pmid":"28437794","pubdate":"2017-04-25T10:11:08+00:00","publisher":"American College of Physicians","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["internalmedicine"],"title":"Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C VirusA Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting SystemHBV-R Associated With DAA Therapy for Chronic HCV","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/hepatitis-b-virus-reactivation-associated-directacting-antiviral-therapy-chronic-hepatitis-c-virus-r"},"altmetric_score":{"score":71.35,"score_history":{"1y":71.35,"6m":71.35,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":71.35},"context_for_score":{"all":{"total_number_of_other_articles":8409255,"mean":7.0791347310873,"rank":129682,"this_scored_higher_than_pct":98,"this_scored_higher_than":8279600,"rank_type":"exact","sample_size":8409255,"percentile":98},"similar_age_3m":{"total_number_of_other_articles":247229,"mean":12.811745409096,"rank":8775,"this_scored_higher_than_pct":96,"this_scored_higher_than":238452,"rank_type":"exact","sample_size":247229,"percentile":96},"this_journal":{"total_number_of_other_articles":8124,"mean":28.19424276745,"rank":639,"this_scored_higher_than_pct":92,"this_scored_higher_than":7485,"rank_type":"exact","sample_size":8124,"percentile":92},"similar_age_this_journal_3m":{"total_number_of_other_articles":157,"mean":93.776769230769,"rank":46,"this_scored_higher_than_pct":70,"this_scored_higher_than":111,"rank_type":"exact","sample_size":157,"percentile":70}}},"demographics":{"poster_types":{"member_of_the_public":37,"researcher":2,"practitioner":9,"science_communicator":3},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":9,"Members of the public":37,"Scientists":2,"Science communicators (journalists, bloggers, editors)":3}},"mendeley":{"by_status":{"Professor > Associate Professor":1,"Librarian":1,"Student  > Master":1},"by_discipline":{"Medicine and Dentistry":3}}},"geo":{"twitter":{"US":11,"IT":1,"ES":4,"BA":1,"FR":1,"JP":4,"DO":1,"KR":1,"GB":2,"ST":1,"AR":1,"CH":2,"MX":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/FranciscoMarty_\/statuses\/856625362360569858","license":"gnip","citation_ids":[19529354],"posted_on":"2017-04-24T21:46:16+00:00","author":{"name":"Francisco Marty, MD","url":"https:\/\/connects.catalyst.harvard.edu\/Profiles\/display\/Person\/25892","image":"https:\/\/pbs.twimg.com\/profile_images\/683135152705409024\/tFlPdopL_normal.jpg","description":"Infectious diseases doctor who specializes in treating transplant and cancer patients, work at @BrighamWomens and @DanaFarber, @harvardmed.","id_on_source":"FranciscoMarty_","tweeter_id":"4693655024","geo":{"lt":42.35843,"ln":-71.05977,"country":"US"},"followers":1321},"tweet_id":"856625362360569858"},{"url":"http:\/\/twitter.com\/kdahal57\/statuses\/856633796095082502","license":"gnip","rt":["FranciscoMarty_"],"citation_ids":[19529354],"posted_on":"2017-04-24T22:19:47+00:00","author":{"name":"kumud dahal","image":"https:\/\/pbs.twimg.com\/profile_images\/2949821637\/24dcca3db72b2a583a2596053ac8f170_normal.jpeg","description":"Interests: Infection in compromised hosts HIV\/ Hep C Tropical Infections Infectious Disease epidemiology","id_on_source":"kdahal57","tweeter_id":"552644651","geo":{"lt":40.00032,"ln":-89.25037,"country":"US"},"followers":182},"tweet_id":"856633796095082502"},{"url":"http:\/\/twitter.com\/Duke_GI_\/statuses\/856661675017199616","license":"gnip","citation_ids":[19529354],"posted_on":"2017-04-25T00:10:33+00:00","author":{"name":"Duke GI","url":"http:\/\/medicine.duke.edu\/divisions\/gastroenterology","image":"https:\/\/pbs.twimg.com\/profile_images\/804076030310825984\/UQRQ8788_normal.jpg","description":"Leader in GI Patient Care, Education, and Research #DukeGI","id_on_source":"Duke_GI_","tweeter_id":"2798533525","geo":{"lt":35.99403,"ln":-78.89862,"country":"US"},"followers":1582},"tweet_id":"856661675017199616"},{"url":"http:\/\/twitter.com\/greg_folkers\/statuses\/856679031286231042","license":"gnip","citation_ids":[19529354],"posted_on":"2017-04-25T01:19:32+00:00","author":{"name":"Greg Folkers","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000063259596\/220c952b0e03de1256e8135015fe9d43_normal.jpeg","description":"washington, dc || personal account || tweets\/retweets \u2260 endorsement || gregfolkers (at) yahoo (dot) com || global health\/infectious diseases","id_on_source":"greg_folkers","tweeter_id":"41626609","geo":{"lt":38.91706,"ln":-77.00025,"country":"US"},"followers":2806},"tweet_id":"856679031286231042"},{"url":"http:\/\/twitter.com\/steveschoi\/statuses\/856692002674675718","license":"gnip","rt":["Duke_GI_"],"citation_ids":[19529354],"posted_on":"2017-04-25T02:11:04+00:00","author":{"name":"Steve Choi","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000387690636\/6241db5e727e6d138900f89887923114_normal.jpeg","id_on_source":"steveschoi","tweeter_id":"1714267782","geo":{"lt":null,"ln":null},"followers":497},"tweet_id":"856692002674675718"},{"url":"http:\/\/twitter.com\/AnnWoolleyMD\/statuses\/856700406306615296","license":"gnip","rt":["FranciscoMarty_"],"citation_ids":[19529354],"posted_on":"2017-04-25T02:44:28+00:00","author":{"name":"Ann Woolley","image":"https:\/\/pbs.twimg.com\/profile_images\/819533339971506176\/z3S6waIT_normal.jpg","id_on_source":"AnnWoolleyMD","tweeter_id":"1389550933","geo":{"lt":null,"ln":null},"followers":59},"tweet_id":"856700406306615296"},{"url":"http:\/\/twitter.com\/DrDeborahFisher\/statuses\/856702057591578624","license":"gnip","rt":["Duke_GI_"],"citation_ids":[19529354],"posted_on":"2017-04-25T02:51:01+00:00","author":{"name":"Dr Deborah Fisher","url":"https:\/\/medicine.duke.edu\/faculty\/deborah-anne-fisher-md","image":"https:\/\/pbs.twimg.com\/profile_images\/711373561001320448\/6XsWaIH5_normal.jpg","description":"Wife, Mom, MD, Researcher, #AcademicswithCats. Tweeting GI, cancer & other health news. Views are mine. No #coffee, no workee Never too early to plan #Halloween","id_on_source":"DrDeborahFisher","tweeter_id":"1543219537","geo":{"lt":35.99403,"ln":-78.89862,"country":"US"},"followers":2083},"tweet_id":"856702057591578624"},{"url":"http:\/\/twitter.com\/mtnhealthcare\/statuses\/856812555293126656","license":"gnip","citation_ids":[19529354],"posted_on":"2017-04-25T10:10:06+00:00","author":{"name":"MHC","url":"http:\/\/www.facebook.com\/mtnhealthcare","image":"https:\/\/pbs.twimg.com\/profile_images\/2845126333\/e08f3eaf96abc83f62b07309714ea824_normal.jpeg","description":"Providing medical care in the Sierra Nevada","id_on_source":"mtnhealthcare","tweeter_id":"921874609","geo":{"lt":null,"ln":null},"followers":1039},"tweet_id":"856812555293126656"},{"url":"http:\/\/twitter.com\/JediPD\/statuses\/856849982305050624","license":"gnip","citation_ids":[19529354],"posted_on":"2017-04-25T12:38:49+00:00","author":{"name":"Parvez Dara MD, MBA","url":"http:\/\/jedismedicine.blogspot.com","image":"https:\/\/pbs.twimg.com\/profile_images\/3159464877\/50f678ee4f79a27f917462f8637cccf5_normal.jpeg","description":"Parvez Dara is a Physician (Medical Hematologist-Oncologist), Pilot, Author, Educator, Husband, Father and Student","id_on_source":"JediPD","tweeter_id":"16132457","geo":{"lt":40.16706,"ln":-74.49987,"country":"US"},"followers":3797},"tweet_id":"856849982305050624"},{"url":"http:\/\/twitter.com\/Tr0ttaFra\/statuses\/856897081046425600","license":"gnip","citation_ids":[19529354],"posted_on":"2017-04-25T15:45:59+00:00","author":{"name":"Francesco Trotta","image":"https:\/\/pbs.twimg.com\/profile_images\/837710433427537921\/PIdSZLh8_normal.jpg","description":"Pharmacoepi researcher, expert in drug regulation. Opinions are my own. RTs do not imply endorsement.","id_on_source":"Tr0ttaFra","tweeter_id":"720582432223817728","geo":{"lt":41.90036,"ln":12.49575,"country":"IT"},"followers":196},"tweet_id":"856897081046425600"},{"url":"http:\/\/twitter.com\/SFManchaC\/statuses\/856962360921214979","license":"gnip","citation_ids":[19529354],"posted_on":"2017-04-25T20:05:23+00:00","author":{"name":"SF-ManchaC","url":"http:\/\/www.serviciofarmaciamanchacentro.es","image":"https:\/\/pbs.twimg.com\/profile_images\/431141000212676608\/z4ZP0GN9_normal.jpeg","description":"Servicio de Farmacia. Hospital Gral La Mancha Centro","id_on_source":"SFManchaC","tweeter_id":"2320631413","geo":{"lt":39.39011,"ln":-3.20827,"country":"ES"},"followers":911},"tweet_id":"856962360921214979"},{"url":"http:\/\/twitter.com\/tomheston\/statuses\/856978419426271232","license":"gnip","citation_ids":[19529354],"posted_on":"2017-04-25T21:09:11+00:00","author":{"name":"Tom Heston","url":"http:\/\/tomheston.com","image":"https:\/\/pbs.twimg.com\/profile_images\/452650157050302464\/-kGG7sgd_normal.png","description":"I help people make wise health decisions. Theese are my medical newsfeed tweets. Follow @tomhestonmd for my personal tweets.","id_on_source":"tomheston","tweeter_id":"21013461","geo":{"lt":44.25,"ln":17.83333,"country":"BA"},"followers":83235},"tweet_id":"856978419426271232"},{"url":"http:\/\/twitter.com\/lfustersanjurjo\/statuses\/856983129944453125","license":"gnip","rt":["SFManchaC"],"citation_ids":[19529354],"posted_on":"2017-04-25T21:27:54+00:00","author":{"name":"Luc\u00eda Fuster Sanjurj","image":"https:\/\/pbs.twimg.com\/profile_images\/691375415252946944\/hpNEcDrG_normal.jpg","description":"FEA Farmacia hospitalaria. CHUFerrol.","id_on_source":"lfustersanjurjo","tweeter_id":"1672575853","geo":{"lt":43.48321,"ln":-8.23689,"country":"ES"},"followers":221},"tweet_id":"856983129944453125"},{"url":"http:\/\/twitter.com\/hivguidelines\/statuses\/857229586085687298","license":"gnip","citation_ids":[19529354],"posted_on":"2017-04-26T13:47:14+00:00","author":{"name":"hivguidelines.org","url":"http:\/\/www.hivguidelines.org","image":"https:\/\/pbs.twimg.com\/profile_images\/823917288478900226\/8JWYALjT_normal.jpg","description":"NYSDOH AI HIV Clinical Guidelines Program. Note: Followers\u2019 tweets and images do not represent the views of http:\/\/hivguidelines.org.","id_on_source":"hivguidelines","tweeter_id":"44004125","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":9989},"tweet_id":"857229586085687298"},{"url":"http:\/\/twitter.com\/EricSALATprof\/statuses\/857310497326215169","license":"gnip","citation_ids":[19529354],"posted_on":"2017-04-26T19:08:45+00:00","author":{"name":"Eric Salat","url":"http:\/\/www.universitedespatients.org","image":"https:\/\/pbs.twimg.com\/profile_images\/905325728379654144\/_WrKdFzm_normal.jpg","description":"#Universite  #Patients @UPMC #Patient #Expert #chroniques #sant\u00e9publique #democratie#sante http:\/www.universitedespatients.org","id_on_source":"EricSALATprof","tweeter_id":"78564079","geo":{"lt":49,"ln":-1,"country":"FR"},"followers":1278},"tweet_id":"857310497326215169"},{"url":"http:\/\/twitter.com\/SandraKoprivnik\/statuses\/857458542093250561","license":"gnip","rt":["SFManchaC"],"citation_ids":[19529354],"posted_on":"2017-04-27T04:57:01+00:00","author":{"name":"Sandra Koprivnik","image":"https:\/\/pbs.twimg.com\/profile_images\/840481644087791616\/67wkLnyX_normal.jpg","id_on_source":"SandraKoprivnik","tweeter_id":"3004165617","geo":{"lt":43.48321,"ln":-8.23689,"country":"ES"},"followers":27},"tweet_id":"857458542093250561"},{"url":"http:\/\/twitter.com\/AnnalsofIM\/statuses\/858425731185086465","license":"gnip","citation_ids":[19529354],"posted_on":"2017-04-29T21:00:17+00:00","author":{"name":"Annals of Int Med","url":"http:\/\/www.annals.org","image":"https:\/\/pbs.twimg.com\/profile_images\/861610916022022146\/OMaA9LSh_normal.jpg","description":"Annals is the flagship journal of the American College of Physicians. With an impact factor of 17.202, Annals ranks 5th among 154 general medicine journals.","id_on_source":"AnnalsofIM","tweeter_id":"120206023","geo":{"lt":39.95234,"ln":-75.16379,"country":"US"},"followers":25693},"tweet_id":"858425731185086465"},{"url":"http:\/\/twitter.com\/mecdarling\/statuses\/858426336431525888","license":"gnip","rt":["AnnalsofIM"],"citation_ids":[19529354],"posted_on":"2017-04-29T21:02:42+00:00","author":{"name":"Marielena Carrera","image":"https:\/\/pbs.twimg.com\/profile_images\/793996890367004672\/48tKHbya_normal.jpg","id_on_source":"mecdarling","tweeter_id":"1345237964","geo":{"lt":null,"ln":null},"followers":41},"tweet_id":"858426336431525888"},{"url":"http:\/\/twitter.com\/jjcrazydiamond\/statuses\/858429967998238720","license":"gnip","rt":["AnnalsofIM"],"citation_ids":[19529354],"posted_on":"2017-04-29T21:17:07+00:00","author":{"name":"T.kimura","image":"https:\/\/pbs.twimg.com\/profile_images\/517326599541125120\/94LlLHIq_normal.jpeg","description":"\u795e\u6238\u306e\u75c5\u9662\u85ac\u5264\u5e2b\u3002 \u611f\u67d3\u75c7\u3001HIV\u3001\u96c6\u4e2d\u6cbb\u7642\u3001\u30dd\u30ea\u30d5\u30a1\u30fc\u30de\u30b7\u30fc\u3001\u962a\u795e\u3001\u91ce\u7403\u3001\u91ce\u7403","id_on_source":"jjcrazydiamond","tweeter_id":"538069163","geo":{"lt":34.6913,"ln":135.183,"country":"JP"},"followers":614},"tweet_id":"858429967998238720"},{"url":"http:\/\/twitter.com\/jlechortiz\/statuses\/858430606421753857","license":"gnip","rt":["AnnalsofIM"],"citation_ids":[19529354],"posted_on":"2017-04-29T21:19:40+00:00","author":{"name":"Jorge Lechuga Ortiz","image":"https:\/\/pbs.twimg.com\/profile_images\/885190897859784704\/iWpeHI46_normal.jpg","description":"No te des por vencido ni aun vencido AUBN (mi maestro). Medicina interna \/ Interesado por la Reumatolog\u00eda. Uninorte - Barranquilla (Colombia)","id_on_source":"jlechortiz","tweeter_id":"2727769757","geo":{"lt":null,"ln":null},"followers":383},"tweet_id":"858430606421753857"},{"url":"http:\/\/twitter.com\/SorayaCastroLL\/statuses\/858434035823017984","license":"gnip","rt":["AnnalsofIM"],"citation_ids":[19529354],"posted_on":"2017-04-29T21:33:17+00:00","author":{"name":"Soraya Castro LLibre","image":"https:\/\/pbs.twimg.com\/profile_images\/843583071244959751\/dNrsFkCc_normal.jpg","id_on_source":"SorayaCastroLL","tweeter_id":"1205267192","geo":{"lt":19,"ln":-70.66667,"country":"DO"},"followers":566},"tweet_id":"858434035823017984"},{"url":"http:\/\/twitter.com\/DrJHK\/statuses\/858466579259867136","license":"gnip","rt":["AnnalsofIM"],"citation_ids":[19529354],"posted_on":"2017-04-29T23:42:36+00:00","author":{"name":"\uae40\uc815\ud55c Jeong Han Kim","url":"http:\/\/facebook.com\/DrJHK","image":"https:\/\/pbs.twimg.com\/profile_images\/624529565591846912\/VNKaSunV_normal.jpg","description":"KUMC Liver","id_on_source":"DrJHK","tweeter_id":"131489001","geo":{"lt":36.5,"ln":127,"country":"KR"},"followers":2630},"tweet_id":"858466579259867136"},{"url":"http:\/\/twitter.com\/Relicena\/statuses\/859073151124340737","license":"gnip","rt":["AnnalsofIM"],"citation_ids":[19529354],"posted_on":"2017-05-01T15:52:54+00:00","author":{"name":"Elena","image":"https:\/\/pbs.twimg.com\/profile_images\/852619697807925251\/WMd8Kp_C_normal.jpg","description":"La ciencia aprende de los errores","id_on_source":"Relicena","tweeter_id":"1255578158","geo":{"lt":40,"ln":-4,"country":"ES"},"followers":44},"tweet_id":"859073151124340737"},{"url":"http:\/\/twitter.com\/AnnalsofIM\/statuses\/863083990072295425","license":"gnip","citation_ids":[19529354],"posted_on":"2017-05-12T17:30:33+00:00","author":{"name":"Annals of Int Med","url":"http:\/\/www.annals.org","image":"https:\/\/pbs.twimg.com\/profile_images\/861610916022022146\/OMaA9LSh_normal.jpg","description":"Annals is the flagship journal of the American College of Physicians. With an impact factor of 17.202, Annals ranks 5th among 154 general medicine journals.","id_on_source":"AnnalsofIM","tweeter_id":"120206023","geo":{"lt":39.95234,"ln":-75.16379,"country":"US"},"followers":25693},"tweet_id":"863083990072295425"},{"url":"http:\/\/twitter.com\/pharmacovig\/statuses\/863153685102288897","license":"gnip","rt":["AnnalsofIM"],"citation_ids":[19529354],"posted_on":"2017-05-12T22:07:29+00:00","author":{"name":"Pharmacovigilance","image":"https:\/\/pbs.twimg.com\/profile_images\/578952762265841664\/bSmi_lmO_normal.jpeg","description":"Independent #pharmacovigilance, #drugsafety and #clinicalsafety tweeter feed for healthcare professionals and patients. #ThinkSafety","id_on_source":"pharmacovig","tweeter_id":"3098052317","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":543},"tweet_id":"863153685102288897"},{"url":"http:\/\/twitter.com\/PotardDechaine\/statuses\/863153974555414528","license":"gnip","citation_ids":[19529354],"posted_on":"2017-05-12T22:08:38+00:00","author":{"name":"Apothicaire Amoureux","url":"http:\/\/www.francoismaignen.co.uk","image":"https:\/\/pbs.twimg.com\/profile_images\/879477796757786624\/FmfoYpkg_normal.jpg","description":"Dr Fran\u00e7ois unleashed (Londinium & Caesaromagus). Pills 'n' Thrills and Bellyaches. Beatles and blur maniac. \ud83c\uddea\ud83c\uddfa\ud83c\uddeb\ud83c\uddf7\ud83c\uddec\ud83c\udde7","id_on_source":"PotardDechaine","tweeter_id":"392267100","geo":{"lt":null,"ln":null},"followers":1155},"tweet_id":"863153974555414528"},{"url":"http:\/\/twitter.com\/pharmacovig\/statuses\/863154618133618690","license":"gnip","citation_ids":[19529354],"posted_on":"2017-05-12T22:11:12+00:00","author":{"name":"Pharmacovigilance","image":"https:\/\/pbs.twimg.com\/profile_images\/578952762265841664\/bSmi_lmO_normal.jpeg","description":"Independent #pharmacovigilance, #drugsafety and #clinicalsafety tweeter feed for healthcare professionals and patients. #ThinkSafety","id_on_source":"pharmacovig","tweeter_id":"3098052317","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":543},"tweet_id":"863154618133618690"},{"url":"http:\/\/twitter.com\/pharmacovig\/statuses\/863155311946985472","license":"gnip","citation_ids":[19529354],"posted_on":"2017-05-12T22:13:57+00:00","author":{"name":"Pharmacovigilance","image":"https:\/\/pbs.twimg.com\/profile_images\/578952762265841664\/bSmi_lmO_normal.jpeg","description":"Independent #pharmacovigilance, #drugsafety and #clinicalsafety tweeter feed for healthcare professionals and patients. #ThinkSafety","id_on_source":"pharmacovig","tweeter_id":"3098052317","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":543},"tweet_id":"863155311946985472"},{"url":"http:\/\/twitter.com\/DrJHK\/statuses\/863158427618484224","license":"gnip","rt":["AnnalsofIM"],"citation_ids":[19529354],"posted_on":"2017-05-12T22:26:20+00:00","author":{"name":"\uae40\uc815\ud55c Jeong Han Kim","url":"http:\/\/facebook.com\/DrJHK","image":"https:\/\/pbs.twimg.com\/profile_images\/624529565591846912\/VNKaSunV_normal.jpg","description":"KUMC Liver","id_on_source":"DrJHK","tweeter_id":"131489001","geo":{"lt":36.5,"ln":127,"country":"KR"},"followers":2630},"tweet_id":"863158427618484224"},{"url":"http:\/\/twitter.com\/holly_pASTRIX\/statuses\/863165566063980544","license":"gnip","rt":["pharmacovig"],"citation_ids":[19529354],"posted_on":"2017-05-12T22:54:42+00:00","author":{"name":"Holly Price","image":"https:\/\/pbs.twimg.com\/profile_images\/869173797739536384\/-cCXA6Z6_normal.jpg","description":"Recruiter w\/ 17 years experience in clinical research. Proud mom of a Type 1 Diabetic looking for a cure!","id_on_source":"holly_pASTRIX","tweeter_id":"339756673","geo":{"lt":35.99403,"ln":-78.89862,"country":"US"},"followers":1365},"tweet_id":"863165566063980544"},{"url":"http:\/\/twitter.com\/Relicena\/statuses\/863504449553281024","license":"gnip","rt":["AnnalsofIM"],"citation_ids":[19529354],"posted_on":"2017-05-13T21:21:18+00:00","author":{"name":"Elena","image":"https:\/\/pbs.twimg.com\/profile_images\/852619697807925251\/WMd8Kp_C_normal.jpg","description":"La ciencia aprende de los errores","id_on_source":"Relicena","tweeter_id":"1255578158","geo":{"lt":40,"ln":-4,"country":"ES"},"followers":44},"tweet_id":"863504449553281024"},{"url":"http:\/\/twitter.com\/carpe_diem0820\/statuses\/867514072815874048","license":"gnip","citation_ids":[19529354],"posted_on":"2017-05-24T22:54:07+00:00","author":{"name":"Mugen UJIIE","url":"http:\/\/researchmap.jp\/mujiie\/?lang=english","image":"https:\/\/pbs.twimg.com\/profile_images\/386293493\/3861485_2349809268_normal.jpg","description":"\u56fd\u969b\u5354\u529b\u306b\u8208\u5473\u304c\u3042\u308a\u3001\u4e88\u9632\u63a5\u7a2e\u3084\u71b1\u5e2f\u533b\u5b66\u306b\u95a2\u9023\u3057\u305f\u4ed5\u4e8b\u3092\u3057\u3066\u3044\u307e\u3059\u3002\u5b66\u3093\u3060\u3053\u3068\u3084\u6700\u8fd1\u306e\u60c5\u5831\u3092\u5171\u6709\u3067\u304d\u305f\u3089\u3068\u601d\u3044\u307e\u3059\u3002 \u6295\u7a3f\u306f\u500b\u4eba\u306b\u3088\u308b\u3082\u306e\u3067\u3001\u6240\u5c5e\u6a5f\u95a2\u7b49\u306e\u610f\u898b\u3084\u8003\u3048\u3068\u95a2\u9023\u3042\u308a\u307e\u305b\u3093\u3002Sharing what I learned through my interests (All tweets my own views)","id_on_source":"carpe_diem0820","tweeter_id":"66077793","geo":{"lt":35.6895,"ln":139.69171,"country":"JP"},"followers":262},"tweet_id":"867514072815874048"},{"url":"http:\/\/twitter.com\/carpe_diem0820\/statuses\/867514449908736001","license":"gnip","citation_ids":[19529354],"posted_on":"2017-05-24T22:55:37+00:00","author":{"name":"Mugen UJIIE","url":"http:\/\/researchmap.jp\/mujiie\/?lang=english","image":"https:\/\/pbs.twimg.com\/profile_images\/386293493\/3861485_2349809268_normal.jpg","description":"\u56fd\u969b\u5354\u529b\u306b\u8208\u5473\u304c\u3042\u308a\u3001\u4e88\u9632\u63a5\u7a2e\u3084\u71b1\u5e2f\u533b\u5b66\u306b\u95a2\u9023\u3057\u305f\u4ed5\u4e8b\u3092\u3057\u3066\u3044\u307e\u3059\u3002\u5b66\u3093\u3060\u3053\u3068\u3084\u6700\u8fd1\u306e\u60c5\u5831\u3092\u5171\u6709\u3067\u304d\u305f\u3089\u3068\u601d\u3044\u307e\u3059\u3002 \u6295\u7a3f\u306f\u500b\u4eba\u306b\u3088\u308b\u3082\u306e\u3067\u3001\u6240\u5c5e\u6a5f\u95a2\u7b49\u306e\u610f\u898b\u3084\u8003\u3048\u3068\u95a2\u9023\u3042\u308a\u307e\u305b\u3093\u3002Sharing what I learned through my interests (All tweets my own views)","id_on_source":"carpe_diem0820","tweeter_id":"66077793","geo":{"lt":35.6895,"ln":139.69171,"country":"JP"},"followers":262},"tweet_id":"867514449908736001"},{"url":"http:\/\/twitter.com\/jjcrazydiamond\/statuses\/867514900079271936","license":"gnip","rt":["carpe_diem0820"],"citation_ids":[19529354],"posted_on":"2017-05-24T22:57:24+00:00","author":{"name":"T.kimura","image":"https:\/\/pbs.twimg.com\/profile_images\/517326599541125120\/94LlLHIq_normal.jpeg","description":"\u795e\u6238\u306e\u75c5\u9662\u85ac\u5264\u5e2b\u3002 \u611f\u67d3\u75c7\u3001HIV\u3001\u96c6\u4e2d\u6cbb\u7642\u3001\u30dd\u30ea\u30d5\u30a1\u30fc\u30de\u30b7\u30fc\u3001\u962a\u795e\u3001\u91ce\u7403\u3001\u91ce\u7403","id_on_source":"jjcrazydiamond","tweeter_id":"538069163","geo":{"lt":34.6913,"ln":135.183,"country":"JP"},"followers":614},"tweet_id":"867514900079271936"},{"url":"http:\/\/twitter.com\/jjcrazydiamond\/statuses\/867514930722881536","license":"gnip","rt":["carpe_diem0820"],"citation_ids":[19529354],"posted_on":"2017-05-24T22:57:31+00:00","author":{"name":"T.kimura","image":"https:\/\/pbs.twimg.com\/profile_images\/517326599541125120\/94LlLHIq_normal.jpeg","description":"\u795e\u6238\u306e\u75c5\u9662\u85ac\u5264\u5e2b\u3002 \u611f\u67d3\u75c7\u3001HIV\u3001\u96c6\u4e2d\u6cbb\u7642\u3001\u30dd\u30ea\u30d5\u30a1\u30fc\u30de\u30b7\u30fc\u3001\u962a\u795e\u3001\u91ce\u7403\u3001\u91ce\u7403","id_on_source":"jjcrazydiamond","tweeter_id":"538069163","geo":{"lt":34.6913,"ln":135.183,"country":"JP"},"followers":614},"tweet_id":"867514930722881536"},{"url":"http:\/\/twitter.com\/kadsho\/statuses\/867519704696446976","license":"gnip","rt":["carpe_diem0820"],"citation_ids":[19529354],"posted_on":"2017-05-24T23:16:29+00:00","author":{"name":"\u9580\u6751\u5c06\u592a Hosp Pharmacist","image":"https:\/\/pbs.twimg.com\/profile_images\/778806726757748737\/QcGpyRcy_normal.jpg","description":"PIC(JSHP)\/IDCP(JSC)\/CNP(JSNP)\/\u85ac\u7269\u7642\u6cd5\u5c02\u9580\u85ac\u5264\u5e2b(JSPHCS) #PharmaceuticalCare, #ClinicalPharmacy, #DI, #Pharmacoepidemiology, #EBM, #AntimicrobialStewardship #ASP","id_on_source":"kadsho","tweeter_id":"168488514","geo":{"lt":43.06417,"ln":141.34694,"country":"JP"},"followers":2133},"tweet_id":"867519704696446976"},{"url":"http:\/\/twitter.com\/h_mikihiro\/statuses\/867522090349416448","license":"gnip","rt":["carpe_diem0820"],"citation_ids":[19529354],"posted_on":"2017-05-24T23:25:58+00:00","author":{"name":"mikihiro.","image":"https:\/\/pbs.twimg.com\/profile_images\/631972195397320704\/ik_ZOeGF_normal.jpg","description":"\u30e1\u30e2\u5e33\u304c\u308f\u308a\u3002","id_on_source":"h_mikihiro","tweeter_id":"496153649","geo":{"lt":null,"ln":null},"followers":144},"tweet_id":"867522090349416448"},{"url":"http:\/\/twitter.com\/wataru20080712\/statuses\/867529635663237120","license":"gnip","rt":["carpe_diem0820"],"citation_ids":[19529354],"posted_on":"2017-05-24T23:55:57+00:00","author":{"name":"Wataru@\u5927\u962aGIM\u30ab\u30f3\u30d5\u30a1","url":"https:\/\/m.facebook.com\/OsakaNishinohouGIM\/","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","description":"\u5185\u79d1\u533b \u611f\u67d3\u75c7 \u7814\u4fee\u533b\u6307\u5c0e \u81ea\u5206\u306e\u5b66\u7fd2\u306a\u3089\u3073\u7814\u4fee\u533b\u5411\u3051\u306b\uff01 \u512a\u79c0\u3067\u306a\u3044\u533b\u5e2b\u306e\u305f\u3081\u306e\u5927\u962a\u897f\u306e\u65b9GIM\u3092\u4e8c\u30f5\u6708\u306b\u4e00\u5ea6\u3084\u3063\u3066\u307e\u3059\u3002\u6b21\u56de\u306f11\/17\u65e5\u751f\u75c5\u9662\u3067\u306e\u4e88\u5b9a\u3002\u5927\u962a\u6025\u6027\u671f\u3001\u516b\u5c3e\u5fb3\u6d32\u4f1a\u3001\u65e5\u751f\u3001JCHO\u5927\u962a\u3001\u962a\u5927\u75c5\u9662\u306e\u5148\u751f\u65b9\u306a\u3069\u304c\u6bce\u56de\u53c2\u52a0\u3057\u3066\u307e\u3059\u3002\u533b\u5b66\u751f\u3082\u53c2\u52a0OK\u3001\u75c7\u4f8b\u3082\u52df\u96c6\u3057\u3066\u307e\u3059\u3002\u3042\u3068\u91e3\u308a\u60c5\u5831\u3082\u305f\u307e\u306b\u3042\u308a\u3002","id_on_source":"wataru20080712","tweeter_id":"198419118","geo":{"lt":1,"ln":7,"country":"ST"},"followers":100},"tweet_id":"867529635663237120"},{"url":"http:\/\/twitter.com\/nakatsu28\/statuses\/867581269571379201","license":"gnip","rt":["carpe_diem0820"],"citation_ids":[19529354],"posted_on":"2017-05-25T03:21:08+00:00","author":{"name":"\u4e2d\u6d25\u5ddd\u4eae","image":"https:\/\/pbs.twimg.com\/profile_images\/2836024374\/3bdf5b5ac7ec2062d79bbeb94d68e7bc_normal.jpeg","description":"\u53f3\u3082\u5de6\u3082\u306a\u304f\u3001\u9811\u5f35\u3063\u3066\u3044\u3066\u3001\u81ea\u5206\u306e\u982d\u3067\u601d\u8003\u3057\u3066\u3001\u771f\u5b9f\u3092\u898b\u3064\u3081\u3066\u3001\u79c1\u6b32\u306a\u304f\u5229\u4ed6\u306e\u7cbe\u795e\u3067\u751f\u304d\u3066\u3044\u308b\u4eba\u304c\u5897\u3048\u3066\u307b\u3057\u3044\u3068\u8003\u3048\u3066\u307e\u3059\u3002\u81ea\u3089\u3082\u305d\u3046\u306a\u308c\u308b\u3088\u3046\u65e5\u3005\u7cbe\u9032\u3002","id_on_source":"nakatsu28","tweeter_id":"275397354","geo":{"lt":null,"ln":null},"followers":2184},"tweet_id":"867581269571379201"},{"url":"http:\/\/twitter.com\/RIQuartette\/statuses\/867604654510587904","license":"gnip","rt":["carpe_diem0820"],"citation_ids":[19529354],"posted_on":"2017-05-25T04:54:03+00:00","author":{"name":"Yutorinashi","image":"https:\/\/pbs.twimg.com\/profile_images\/1792160583\/2_normal.jpg","description":"\u75c5\u9662\u85ac\u5264\u5e2b\u3067\u3059\u3002\u3088\u308d\u3057\u304f\u304a\u9858\u3044\u3057\u307e\u3059\u3002","id_on_source":"RIQuartette","tweeter_id":"475582612","geo":{"lt":null,"ln":null},"followers":735},"tweet_id":"867604654510587904"},{"url":"http:\/\/twitter.com\/takashtoy\/statuses\/867616361727500288","license":"gnip","rt":["carpe_diem0820"],"citation_ids":[19529354],"posted_on":"2017-05-25T05:40:34+00:00","author":{"name":"Toya","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","description":"\u8840\u6db2\u30fb\u816b\u760d\u5185\u79d1\u533b","id_on_source":"takashtoy","tweeter_id":"953802180","geo":{"lt":null,"ln":null},"followers":108},"tweet_id":"867616361727500288"},{"url":"http:\/\/twitter.com\/kawalle\/statuses\/867695210951720960","license":"gnip","rt":["carpe_diem0820"],"citation_ids":[19529354],"posted_on":"2017-05-25T10:53:53+00:00","author":{"name":"RP\uff20\u7269\u8b70\u3092\u91b8\u3059\u30ef\u30af\u30c1\u30f3","image":"https:\/\/pbs.twimg.com\/profile_images\/868306956615798784\/bSo7tqur_normal.jpg","description":"\u30ef\u30af\u30c1\u30f3\u798d\u3092\u6182\u616e\u3057\u307e\u3059\uff0f\u30ef\u30af\u30c1\u30f3\u3067\u307c\u308d\u5132\u3051\u3092\u76ee\u8ad6\u3080\u5c0f\u5150\u79d1\u533b\u30fb\u5a66\u4eba\u79d1\u533b\u306b\u6c17\u3092\u3064\u3051\u3066\uff0f\u8cdb\u6210\u53cd\u5bfe\u306e\u865a\u3057\u3044\u7f75\u308a\u5408\u3044\u3067\u306f\u306a\u304f\u672c\u5f53\u306b\u5fc5\u8981\u306a\u30ef\u30af\u30c1\u30f3\u3060\u3051\u3092\u9078\u3093\u3067\u63a5\u7a2e\u3059\u308b\u305f\u3081\u306b\uff0f \u65b0\u88fd\u54c1\u306e\u30ef\u30af\u30c1\u30f3\u306f\u98db\u3073\u3064\u304b\u306a\u3044\u3067\u69d8\u5b50\u898b\uff0f\u5148\u884c\u3059\u308b\u6d77\u5916\u306e\u60c5\u5831\u3082\u53c2\u8003\u306b\uff0f\uff0f\u74b0\u5883\uff0f\u53cd\u6226\uff0f\u52d5\u7269\u611b\u8b77\uff0f \u7a40\u83dc\u98df\u4e3b\u7fa9\uff0f\u5de5\u5834\u755c\u7523\uff0f\u53d7\u52d5\u55ab\u7159\u88ab\u5bb3","id_on_source":"kawalle","tweeter_id":"425107126","geo":{"lt":35.68536,"ln":139.75309,"country":"JP"},"followers":1944},"tweet_id":"867695210951720960"},{"url":"http:\/\/twitter.com\/raspberrymxtxax\/statuses\/867715992008269825","license":"gnip","rt":["carpe_diem0820"],"citation_ids":[19529354],"posted_on":"2017-05-25T12:16:28+00:00","author":{"name":"raspberry","image":"https:\/\/pbs.twimg.com\/profile_images\/2438108136\/137_normal.jpg","description":"\u7d05\u8336\u306e\u4e2d\u3067\u306f\u3061\u3087\u3063\u3068\u7656\u306e\u3042\u308b\u30a2\u30fc\u30eb\u30b0\u30ec\u30a4\u304c\u597d\u304d\u3067\u3059\u3002","id_on_source":"raspberrymxtxax","tweeter_id":"720036704","geo":{"lt":null,"ln":null},"followers":70},"tweet_id":"867715992008269825"},{"url":"http:\/\/twitter.com\/ruruuuuwn\/statuses\/867880193955733505","license":"gnip","rt":["carpe_diem0820"],"citation_ids":[19529354],"posted_on":"2017-05-25T23:08:57+00:00","author":{"name":"\u308b\u3046=\u9f8d","url":"http:\/\/ruruuun.hatenablog.com","image":"https:\/\/pbs.twimg.com\/profile_images\/891442461305839616\/Mx5zuKSt_normal.jpg","description":"\u3093\u306f\u306f\u306e\u672c\u68da\u30a2\u30ab\u30a6\u30f3\u30c8\/\/\u306a\u306a\u3081\u4e0a\u3092\u76ee\u6307\u3057\u3066\u3044\u3053\u3046","id_on_source":"ruruuuuwn","tweeter_id":"3252610897","geo":{"lt":null,"ln":null},"followers":100},"tweet_id":"867880193955733505"},{"url":"http:\/\/twitter.com\/GarbineLizeaga\/statuses\/871945825022332928","license":"gnip","citation_ids":[19529354],"posted_on":"2017-06-06T04:24:19+00:00","author":{"name":"Garbi\u00f1e Lizeaga","image":"https:\/\/pbs.twimg.com\/profile_images\/786651537573572608\/fOvQvTXd_normal.jpg","description":"FHyAP. OSI Donostialdea. De todo como en botica.","id_on_source":"GarbineLizeaga","tweeter_id":"2244183212","geo":{"lt":null,"ln":null},"followers":409},"tweet_id":"871945825022332928"},{"url":"http:\/\/twitter.com\/rubenroa\/statuses\/872827202290806785","license":"gnip","citation_ids":[19529354],"posted_on":"2017-06-08T14:46:36+00:00","author":{"name":"Ruben Roa","url":"http:\/\/medicina-general-familiar.blogspot.com","image":"https:\/\/pbs.twimg.com\/profile_images\/428849770891710464\/kgRmDYTd_normal.png","description":"Family Doctor & Epidemiologist & Health Technology Assesment","id_on_source":"rubenroa","tweeter_id":"35991485","geo":{"lt":-34.61315,"ln":-58.37723,"country":"AR"},"followers":1862},"tweet_id":"872827202290806785"},{"url":"http:\/\/twitter.com\/JooCastillo\/statuses\/873297684731273216","license":"gnip","citation_ids":[19529354],"posted_on":"2017-06-09T21:56:07+00:00","author":{"name":"Jorge","image":"https:\/\/pbs.twimg.com\/profile_images\/744352795692695552\/FkE3Q9l2_normal.jpg","id_on_source":"JooCastillo","tweeter_id":"110280607","geo":{"lt":null,"ln":null},"followers":130},"tweet_id":"873297684731273216"},{"url":"http:\/\/twitter.com\/AnnalsofIM\/statuses\/873646152486440963","license":"gnip","citation_ids":[19529354],"posted_on":"2017-06-10T21:00:48+00:00","author":{"name":"Annals of Int Med","url":"http:\/\/www.annals.org","image":"https:\/\/pbs.twimg.com\/profile_images\/861610916022022146\/OMaA9LSh_normal.jpg","description":"Annals is the flagship journal of the American College of Physicians. With an impact factor of 17.202, Annals ranks 5th among 154 general medicine journals.","id_on_source":"AnnalsofIM","tweeter_id":"120206023","geo":{"lt":39.95234,"ln":-75.16379,"country":"US"},"followers":25693},"tweet_id":"873646152486440963"},{"url":"http:\/\/twitter.com\/ARAdultImmDoc\/statuses\/873652249750274049","license":"gnip","rt":["AnnalsofIM"],"citation_ids":[19529354],"posted_on":"2017-06-10T21:25:02+00:00","author":{"name":"Robert Hopkins","image":"https:\/\/pbs.twimg.com\/profile_images\/909758930544361475\/IsD7vQfU_normal.jpg","description":"\ud83c\uddfa\ud83c\uddf8Med-Peds MD-educator. Foci: Immunization, Pt-Centered Quality Care. Healthcare IS a right. #Resist Tweets=MY opinion alone, not medical advice.","id_on_source":"ARAdultImmDoc","tweeter_id":"2470812752","geo":{"lt":34.74648,"ln":-92.28959,"country":"US"},"followers":1343},"tweet_id":"873652249750274049"},{"url":"http:\/\/twitter.com\/KLevittMDMPH\/statuses\/873655691231277056","license":"gnip","rt":["AnnalsofIM"],"citation_ids":[19529354],"posted_on":"2017-06-10T21:38:43+00:00","author":{"name":"Kimberly Levitt MD","image":"https:\/\/pbs.twimg.com\/profile_images\/797488653568245761\/OxLwJ3ht_normal.jpg","description":"BoardCertFamilyMedicine;Jefferson Medical College;MPH:Johns Hopkins;Residency:St.Joseph's Family Medicine, Phoenix,Az;Internship:NYMethodistED;Acupuncture: UCLA","id_on_source":"KLevittMDMPH","tweeter_id":"797482686969507840","geo":{"lt":null,"ln":null},"followers":157},"tweet_id":"873655691231277056"},{"url":"http:\/\/twitter.com\/pharmacovig\/statuses\/873657212383657985","license":"gnip","rt":["AnnalsofIM"],"citation_ids":[19529354],"posted_on":"2017-06-10T21:44:45+00:00","author":{"name":"Pharmacovigilance","image":"https:\/\/pbs.twimg.com\/profile_images\/578952762265841664\/bSmi_lmO_normal.jpeg","description":"Independent #pharmacovigilance, #drugsafety and #clinicalsafety tweeter feed for healthcare professionals and patients. #ThinkSafety","id_on_source":"pharmacovig","tweeter_id":"3098052317","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":543},"tweet_id":"873657212383657985"},{"url":"http:\/\/twitter.com\/its_only_r_n_r\/statuses\/873672152310009860","license":"gnip","rt":["AnnalsofIM"],"citation_ids":[19529354],"posted_on":"2017-06-10T22:44:07+00:00","author":{"name":"Christos Koutsianas","image":"https:\/\/pbs.twimg.com\/profile_images\/862993707158646785\/PXaWoLfR_normal.jpg","description":"There's a feeling I get\nWhen I look to the west,\nAnd my spirit is crying for leaving.","id_on_source":"its_only_r_n_r","tweeter_id":"2899094488","geo":{"lt":52.48142,"ln":-1.89983,"country":"GB"},"followers":61},"tweet_id":"873672152310009860"},{"url":"http:\/\/twitter.com\/SilviaPorto88\/statuses\/873677853266673664","license":"gnip","rt":["AnnalsofIM"],"citation_ids":[19529354],"posted_on":"2017-06-10T23:06:47+00:00","author":{"name":"Silvia Su\u00e1rez","image":"https:\/\/pbs.twimg.com\/profile_images\/695378103636340736\/wdCdCYlx_normal.jpg","id_on_source":"SilviaPorto88","tweeter_id":"185024859","geo":{"lt":null,"ln":null},"followers":92},"tweet_id":"873677853266673664"},{"url":"http:\/\/twitter.com\/kdahal57\/statuses\/873683875091927040","license":"gnip","rt":["AnnalsofIM"],"citation_ids":[19529354],"posted_on":"2017-06-10T23:30:42+00:00","author":{"name":"kumud dahal","image":"https:\/\/pbs.twimg.com\/profile_images\/2949821637\/24dcca3db72b2a583a2596053ac8f170_normal.jpeg","description":"Interests: Infection in compromised hosts HIV\/ Hep C Tropical Infections Infectious Disease epidemiology","id_on_source":"kdahal57","tweeter_id":"552644651","geo":{"lt":40.00032,"ln":-89.25037,"country":"US"},"followers":182},"tweet_id":"873683875091927040"},{"url":"http:\/\/twitter.com\/OlallaJulian\/statuses\/873949204095401984","license":"gnip","rt":["AnnalsofIM"],"citation_ids":[19529354],"posted_on":"2017-06-11T17:05:02+00:00","author":{"name":"Juli\u00e1n Olalla","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000290704734\/9d40162202ce6ec863d9ce82a813ab4a_normal.jpeg","id_on_source":"OlallaJulian","tweeter_id":"1668801289","geo":{"lt":null,"ln":null},"followers":84},"tweet_id":"873949204095401984"},{"url":"http:\/\/twitter.com\/clairepomeroy\/statuses\/876780954542522368","license":"gnip","citation_ids":[19529354],"posted_on":"2017-06-19T12:37:24+00:00","author":{"name":"Dr. Claire Pomeroy","url":"http:\/\/www.laskerfoundation.org","image":"https:\/\/pbs.twimg.com\/profile_images\/464420885982502912\/y1E3d6Th_normal.jpeg","description":"Claire Pomeroy is President of the Albert and Mary Lasker Foundation. @LaskerFDN","id_on_source":"clairepomeroy","tweeter_id":"2447961475","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":361},"tweet_id":"876780954542522368"},{"url":"http:\/\/twitter.com\/clairepomeroy\/statuses\/877131571215695872","license":"gnip","citation_ids":[19529354],"posted_on":"2017-06-20T11:50:37+00:00","author":{"name":"Dr. Claire Pomeroy","url":"http:\/\/www.laskerfoundation.org","image":"https:\/\/pbs.twimg.com\/profile_images\/464420885982502912\/y1E3d6Th_normal.jpeg","description":"Claire Pomeroy is President of the Albert and Mary Lasker Foundation. @LaskerFDN","id_on_source":"clairepomeroy","tweeter_id":"2447961475","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":361},"tweet_id":"877131571215695872"},{"url":"http:\/\/twitter.com\/ESOTtransplant\/statuses\/877395061188722693","license":"gnip","rt":["clairepomeroy"],"citation_ids":[19529354],"posted_on":"2017-06-21T05:17:38+00:00","author":{"name":"ESOTtransplant","url":"http:\/\/www.esot.org","image":"https:\/\/pbs.twimg.com\/profile_images\/1527831388\/ESOTdef2009_small_normal.jpg","description":"European Society for Organ Transplantation supports members&friends #ESOTtrustedPartner Transplant Professionals #ESOT2017 . Retweets are not an endorsement","id_on_source":"ESOTtransplant","tweeter_id":"367612772","geo":{"lt":null,"ln":null},"followers":1786},"tweet_id":"877395061188722693"},{"url":"http:\/\/twitter.com\/JHepatology\/statuses\/877395524118343681","license":"gnip","rt":["clairepomeroy"],"citation_ids":[19529354],"posted_on":"2017-06-21T05:19:28+00:00","author":{"name":"Journal Hepatology","url":"http:\/\/www.journal-of-hepatology.eu","image":"https:\/\/pbs.twimg.com\/profile_images\/534704110344237057\/4oyP3BJQ_normal.png","description":"Official journal of @EASLnews   Geneva\/Switzerland - EASL does not express any political opinion -  RT \u2260 endorsement \n#hepatology #medicine #liver #healthcare","id_on_source":"JHepatology","tweeter_id":"862974992","geo":{"lt":46.16667,"ln":6.16667,"country":"CH"},"followers":6212},"tweet_id":"877395524118343681"},{"url":"http:\/\/twitter.com\/marian_berrospe\/statuses\/877395981800689664","license":"gnip","rt":["clairepomeroy"],"citation_ids":[19529354],"posted_on":"2017-06-21T05:21:17+00:00","author":{"name":"Marian Berrospe","image":"https:\/\/pbs.twimg.com\/profile_images\/906861874418876416\/rbYQKMzm_normal.jpg","description":"La vida te puede arrebatar una parte de ti y sentir que mueres, pero tambi\u00e9n te da tesoros invaluables  y momentos bellos inesperados.","id_on_source":"marian_berrospe","tweeter_id":"816476894128259072","geo":{"lt":20.66682,"ln":-103.39182,"country":"MX"},"followers":19},"tweet_id":"877395981800689664"},{"url":"http:\/\/twitter.com\/LZacchilli\/statuses\/877397365015105536","license":"gnip","rt":["clairepomeroy"],"citation_ids":[19529354],"posted_on":"2017-06-21T05:26:47+00:00","author":{"name":"Luigi Zacchilli","image":"https:\/\/pbs.twimg.com\/profile_images\/880696131386314752\/ceO3FZoY_normal.jpg","id_on_source":"LZacchilli","tweeter_id":"2740675678","geo":{"lt":null,"ln":null},"followers":40},"tweet_id":"877397365015105536"},{"url":"http:\/\/twitter.com\/VersantisAG\/statuses\/877450891971919872","license":"gnip","rt":["clairepomeroy"],"citation_ids":[19529354],"posted_on":"2017-06-21T08:59:29+00:00","author":{"name":"Versantis AG","url":"http:\/\/www.versantis.ch","image":"https:\/\/pbs.twimg.com\/profile_images\/847007267836891136\/wfqlKZ_Y_normal.jpg","description":"Versantis is a Swiss pharmaceutical company developing new generations of liver disease medicines and diagnostics addressing high unmet medical needs.","id_on_source":"VersantisAG","tweeter_id":"847004554633887745","geo":{"lt":47.41667,"ln":8.66667,"country":"CH"},"followers":28},"tweet_id":"877450891971919872"},{"url":"http:\/\/twitter.com\/steveschoi\/statuses\/877471023251296256","license":"gnip","rt":["clairepomeroy"],"citation_ids":[19529354],"posted_on":"2017-06-21T10:19:29+00:00","author":{"name":"Steve Choi","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000387690636\/6241db5e727e6d138900f89887923114_normal.jpeg","id_on_source":"steveschoi","tweeter_id":"1714267782","geo":{"lt":null,"ln":null},"followers":497},"tweet_id":"877471023251296256"},{"url":"http:\/\/twitter.com\/OysterHC\/statuses\/877570603087257600","license":"gnip","citation_ids":[19529354],"posted_on":"2017-06-21T16:55:10+00:00","author":{"name":"Oyster Healthcare","url":"http:\/\/www.oysterhc.co.uk","image":"https:\/\/pbs.twimg.com\/profile_images\/449545595649155072\/Hl4HHoIy_normal.png","description":"Communication with HCPs & people with long-term conditions through magazines, information packs, education programmes & more. #makethecomplexclear","id_on_source":"OysterHC","tweeter_id":"976237597","geo":{"lt":null,"ln":null},"followers":311},"tweet_id":"877570603087257600"},{"url":"http:\/\/twitter.com\/clairepomeroy\/statuses\/877677840313012224","license":"gnip","citation_ids":[19529354],"posted_on":"2017-06-22T00:01:18+00:00","author":{"name":"Dr. Claire Pomeroy","url":"http:\/\/www.laskerfoundation.org","image":"https:\/\/pbs.twimg.com\/profile_images\/464420885982502912\/y1E3d6Th_normal.jpeg","description":"Claire Pomeroy is President of the Albert and Mary Lasker Foundation. @LaskerFDN","id_on_source":"clairepomeroy","tweeter_id":"2447961475","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":361},"tweet_id":"877677840313012224"}],"news":[{"title":"Direct-acting antiviral therapy for hepatitis C virus associated with hepatitis B virus reactivation in co-infected patients | 2 Minute Medicine","url":"http:\/\/ct.moreover.com\/?a=30346166623&p=1pl&v=1&x=cBgXEycLH2n3HdHeeCrBUQ","license":"public","citation_ids":[19529354,6260819],"posted_on":"2017-04-25T04:01:14+00:00","summary":"1. Patients who have been infected with hepatitis B virus (HBV) and are being treated with direct-acting antiviral agents (DAAs) for hepatitis C virus (HCV) infection should be monitored during their treatment course for possible development of HBV\u2026","author":{"name":"2 Minute Medicine ","url":"http:\/\/www.2minutemedicine.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/278\/normal\/Screen_Shot_2014-11-20_at_11.49.13.png?1416484181"}},{"title":"HBV Reactivation Is Concern With DAA Tx in HBV-HCV Coinfection","url":"http:\/\/ct.moreover.com\/?a=30352855565&p=1pl&v=1&x=XYXjUWUW1okIku6ioNKFpg","license":"public","citation_ids":[19529354,19529354],"posted_on":"2017-04-25T16:22:58+00:00","summary":"(HealthDay News) -- Hepatitis B virus (HBV) reactivation (HBV-R) is a safety concern for patients with HBV and hepatitis C virus (HCV) coinfection receiving direct-acting antiviral agents (DAAs), according to a study published online April 24 in the\u2026","author":{"name":"Physician's Briefing","url":"http:\/\/www.physiciansbriefing.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/372\/normal\/logo.png?1436525474"}},{"title":"No Consistent Pattern of HBV Reactivation With Direct-acting Antivirals for HCV","url":"http:\/\/ct.moreover.com\/?a=30355285081&p=1pl&v=1&x=5Z2bVWwMn6cw58kO299HzQ","license":"public","citation_ids":[19529354,19529354],"posted_on":"2017-04-25T20:52:40+00:00","summary":"NEW YORK (Reuters Health) - The largest case review to date of hepatitis B virus (HBV) reactivation associated with direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection found no consistent pattern in terms of which\u2026","author":{"name":"Medscape","url":"http:\/\/medscape.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/055\/normal\/medscape.png?1369846939"}},{"title":"HBV reactivation is concern with DAA Tx in HBV-HCV coinfection","url":"http:\/\/ct.moreover.com\/?a=30355197342&p=1pl&v=1&x=qGJyuycU8DGTMZGnQ-lm0Q","license":"public","citation_ids":[19529354],"posted_on":"2017-04-25T20:42:40+00:00","summary":"(HealthDay)\u2014Hepatitis B virus (HBV) reactivation (HBV-R) is a safety concern for patients with HBV and hepatitis C virus (HCV) coinfection receiving direct-acting antiviral agents (DAAs), according to a study published online April 24 in the Annals\u2026","author":{"name":"MedicalXpress","url":"http:\/\/medicalxpress.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/152\/normal\/image.png?1369925783"}},{"title":"April 2017 Briefing - OBGYN & Women's Health","url":"http:\/\/ct.moreover.com\/?a=30419411031&p=1pl&v=1&x=m8zIAMebWV-RnfWRh-IlWg","license":"public","citation_ids":[19144044,19646721,19616400,19648879,19563228,19564504,19562266,19568825,19533256,19528789,19529821,19188403,19188665,19236749,19236749,18793597,17396516,17396516,19226926,19226926,18066954,18790877,18790877,18910266,18911974,18734267,14500434,14500434,18913241,18808817,19143442,18925116,18925116,19100751,19098774,18583923,18913723,18598364,18907478,18907478,18905418,18905418,18697241,18697241,18790932,18790932,18787032,18787032,18910931,18910931,18728884,18781970,18795005,18795005,18563201,18704994,18805190,18805190,18782645,18782990,18782787,18783142,18783142,18767470,18636402,18636402,18785543,18785543,18560451,18560451,18463319,18463319,18726682,18559756,18559756,18700922,18703038,18700688,18707125,18707125,13803683,13803683,18187123,19156355,19156355,19514068,19514068,19186270,19186270,19649261,19195540,19195540,19204132,19204132,19615060,19648961,19648961,19608589,19624032,19624032,19216712,17392296,17392296,18805231,18824778,19529354,19220683,18308598,18308598,18797489,19194695,19194695,19247043,19247043,18786735,19247081,18910288,18611771,18611771,19143414,19144461,19144795,19144795,18739492,18739492,18749754,18749754,18808466,18638272,18818003,18544190,18544190,18782997,18782997,18783030,18700622,18635362,18635362,18706952,18706061,13088643,13088643,18698953,18692314,18692314,19580227,19580227,19627670,19616324,15699050,15699050,19610886,16897001,16897001,19526108,19624230,19156636,19156636,19534209,19534209,19534436,19534436,19519363,19428209,19225181,19507617,19507617,19507612,19246823,19246823,13258253,13258253,19213405,18782529,18893596,18893596,13608988,13608988,15575500,18726006,18781728,12606060,12606060,15147774,15147774,18700687,15571369,15571369,18694823,18694823,18701309,16187189,19641829,19641829,19677020,19529278,19527347,19527347,18801752,19219468,19218686,19228057,19228057,18737015,18737015,18913467,18706260,18706261,18702517,18702517,18880713,18880713,18443914,18443914,17083152,17084663,18782856,18201429,18201429,18771105,18771105,18486060,18486060,17179960,17179960,18337870,18337870],"posted_on":"2017-05-01T15:50:04+00:00","summary":"Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women's Health for April 2017.","author":{"name":"Physician's Briefing","url":"http:\/\/www.physiciansbriefing.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/372\/normal\/logo.png?1436525474"}},{"title":"April 2017 Briefing - Gastroenterology","url":"http:\/\/ct.moreover.com\/?a=30418581331&p=1pl&v=1&x=Dk-10MBi5jRTLf83JLGzQQ","license":"public","citation_ids":[19144044,19580227,19580227,19624032,19624032,19216712,19564043,19529354,19527347,19527347,18583923,18697241,18697241,18739492,18739492,18798648,18805190,18805190,15147774,15147774,15571369,15571369,18707125,18707125,15227154,15227154,16914786,16056297,16056297,18561179,18245236,18245236,16547048,16547048,18498537,18489263,18489263,18498848,18498848,18310218,18310218,16904190,18453096,18457397,19641829,19641829,19677020,19648961,19648961,19531389,19568825,19534436,19534436,19247081,19247043,19247043,19194695,19194695,18801752,19226926,19226926,18913467,18925116,18925116,19144781,16135301,16135301,18704812,18723533,17083152,17084663,18818003,18720198,18707635,18705599,17408486,17408486,18337870,18337870,18692314,18692314,18692467,18430287,18430287,18488165,19534209,19534209,19245742,19213405,19236749,19236749,18793597,18782529,19143414,18913241,18808817,13608988,13608988,15575500,18781728,16187189,16187189,16718686,16718686,12598989,12598989,18172634,18560353,18488940,18153746,18153746,18454694,18457075,19616400,19648879,19195540,19195540,19204132,19204132,19529821,19228057,19228057,18910931,18910931,18294625,18691614,18691614,18767470,18726630,18727903,18771105,18771105,18595511,18532728,18532728,18007919,18007919,19649261,19615060,19428209,18919729,18919729,19187490,19187535,19144461,19144795,19144795,18726006,18911171,18911172,18706952,19642881,19642881,18805231,19208051,19208051,18910266,18911974,18702517,18702517,18795005,18795005,18563201,12606060,12606060,18560410,18533000,18533000,18309237,16897001,16897001,19578687,19225181,18645413,18645413,18706061,18728244,18728244,18701309,18169309,18169309],"posted_on":"2017-05-01T14:15:18+00:00","summary":"Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for April 2017.","author":{"name":"Physician's Briefing","url":"http:\/\/www.physiciansbriefing.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/372\/normal\/logo.png?1436525474"}},{"title":"April 2017 Briefing - Emergency Medicine","url":"http:\/\/ct.moreover.com\/?a=30418710760&p=1pl&v=1&x=kthPiM_LxClVHb3X01MylA","license":"public","citation_ids":[19144044,19648961,19648961,19616049,19531389,19529278,19520073,19534436,19534436,19220683,18308598,18308598,19194695,19194695,19247043,19247043,19213405,18801752,19226926,19226926,18611771,18611771,19143414,18913467,18925116,18925116,19144795,19144795,18697241,18697241,18704812,18723533,17083152,17084663,18782856,18720198,18707635,12606060,12606060,18706952,18700687,18707125,18707125,16056297,16056297,18245236,18245236,18165074,18165074,18310218,18310218,16904190,19641829,19641829,19677020,19624032,19624032,19568825,19247081,19144781,16135301,16135301,18818003,18705599,17408486,17408486,18337870,18337870,18692314,18692314,18692467,18430287,18430287,18488165,19580227,19580227,19534209,19534209,19529354,19245742,19236749,19236749,18793597,18782529,18913241,18808817,13608988,13608988,15575500,18781728,15571369,15571369,16187189,16187189,16718686,16718686,12598989,12598989,18172634,18560353,18561179,18498537,18489263,18489263,18488940,18153746,18153746,18454694,18457075,19616400,19608589,17392296,17392296,19533256,19529821,19520547,19246823,19246823,18910288,19155198,19100751,19098774,18913723,18907478,18907478,18905418,18905418,18787032,18787032,18636402,18636402,18767470,18560451,18560451,18463319,18463319,18726682,17179960,17179960,18532902,18637388,18637388,18451011,18451011,18560410,18488225,18579462,18579462,18453096,18457397,19156355,19156355,19186270,19186270,19195540,19195540,19204132,19204132,19648879,18910931,18910931,18294625,18785543,18785543,18726630,18727903,18771105,18771105,18694823,18694823],"posted_on":"2017-05-01T14:30:24+00:00","summary":"Here are what the editors at HealthDay consider to be the most important developments in Emergency Medicine for April 2017.","author":{"name":"Physician's Briefing","url":"http:\/\/www.physiciansbriefing.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/372\/normal\/logo.png?1436525474"}},{"title":"April 2017 Briefing - Pulmonology","url":"http:\/\/ct.moreover.com\/?a=30419416615&p=1pl&v=1&x=v9fwVwJ78znxxx_p34sNWQ","license":"public","citation_ids":[19144044,19610886,19534209,19534209,19156636,19156636,19526108,19624230,16897001,16897001,19534436,19534436,18801752,18782529,19226926,19226926,14500434,14500434,18913467,18706260,18706261,18702517,18702517,16135301,16135301,18487517,18697241,18697241,18781728,18782997,18782997,18783030,18805190,18805190,18720198,18707635,17408486,17408486,18559756,18559756,18337870,18337870,18692314,18692314,18692467,18707125,18707125,18384440,18384440,18560410,18538685,18566607,18245236,18245236,18536763,18489263,18489263,18153746,18153746,18454694,18310218,18310218,16904190,18457075,18199102,18469337,18165168,18165168,18309237,19580227,19580227,19648961,19648961,19529354,19245742,19247043,19247043,19213405,19236749,19236749,18793597,19143414,18913241,18808817,18925116,18925116,13608988,13608988,15575500,15571369,15571369,16187189,16187189,16718686,16718686,12598989,12598989,18172634,18560353,18561179,18498537,18488940,18430287,18430287,19616400,19608589,19531389,17392296,17392296,19533256,19529821,19220683,19520547,19246823,19246823,18910288,19155198,19100751,19098774,18913723,18907478,18907478,18905418,18905418,18787032,18787032,18636402,18636402,18767470,18560451,18560451,18463319,18463319,18726682,17179960,17179960,18532902,18637388,18637388,18451011,18451011,18488225,18579462,18579462,18165074,18165074,18453096,18457397,19156355,19156355,19616248,19616248,19616324,19219468,19218686,18893596,18893596,19228057,19228057,19143442,19144461,18598364,18880713,18880713,18749754,18749754,18808466,18818003,18563201,18785543,18785543,18599750,18599750,18700687,18536581,18615043,18536607,18536607,18537892,18532582,18538368,18488165,18461780,19616049,19529278,19520073,18308598,18308598,19194695,19194695,18611771,18611771,19144795,19144795,18704812,18723533,17083152,17084663,18782856,12606060,12606060,18706952,16056297,16056297,19646721,19649261,19216712,18805231,18824778,19528789,18797489,19188403,19188665,18786735,19187490,19187535,17396516,17396516,18066954,18734267,18737015,18737015,18726006,18790932,18790932,18638272,18782645,18782990,18782787,18700622,18733243,13088643,13088643,18500039,18500039,18595511,18503256,18532728,18532728,18465633,18507919,18507919,18519148,18007919,18007919,18464889,18476559,19514068,19514068,19615060,19627670,19578687,19247081,19144781,18780233,18780233,18691614,18691614,18705599,18702468,18701309,18533000,18533000,18169309,18169309,18462934,18037264,18037264],"posted_on":"2017-05-01T15:50:39+00:00","summary":"Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for April 2017.","author":{"name":"Physician's Briefing","url":"http:\/\/www.physiciansbriefing.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/372\/normal\/logo.png?1436525474"}},{"title":"April 2017 Briefing - Psychiatry","url":"http:\/\/ct.moreover.com\/?a=30419543423&p=1pl&v=1&x=yFukKkrS8qmvJv2xl8IV-Q","license":"public","citation_ids":[19144044,19580227,19580227,19616400,19608589,19531389,17392296,17392296,19533256,19529821,19220683,19520547,19246823,19246823,18910288,19155198,19100751,19098774,18913723,18907478,18907478,18905418,18905418,18697241,18697241,18787032,18787032,18636402,18636402,18767470,18560451,18560451,18463319,18463319,18726682,17179960,17179960,18707125,18707125,18692314,18692314,18692467,18532902,18637388,18637388,18451011,18451011,18560410,18245236,18245236,18489263,18489263,18488225,18579462,18579462,18165074,18165074,16904190,18453096,18457397,19641829,19641829,19677020,19648961,19648961,19624032,19624032,19568825,19534436,19534436,19247081,19247043,19247043,19194695,19194695,18801752,19226926,19226926,18913467,18925116,18925116,19144781,16135301,16135301,18704812,18723533,17083152,17084663,18818003,18720198,18707635,18705599,17408486,17408486,18337870,18337870,18430287,18430287,18488165,18310218,18310218,19534209,19534209,19529354,19245742,19213405,19236749,19236749,18793597,18782529,19143414,18913241,18808817,13608988,13608988,15575500,18781728,15571369,15571369,16187189,16187189,16718686,16718686,12598989,12598989,18172634,18560353,18561179,18498537,18488940,18153746,18153746,18454694,18457075,19156355,19156355,19616248,19616248,19616324,19219468,19218686,18893596,18893596,19228057,19228057,19143442,19144461,18702517,18702517,18598364,18880713,18880713,18749754,18749754,18808466,18563201,18785543,18785543,18599750,18599750,18700687,18536581,18615043,18536607,18536607,18537892,18532582,18538368,18461780,19616049,19529278,19520073,18308598,18308598,18611771,18611771,19144795,19144795,18782856,12606060,12606060,18706952,16056297,16056297],"posted_on":"2017-05-01T16:04:48+00:00","summary":"Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for April 2017.","author":{"name":"Physician's Briefing","url":"http:\/\/www.physiciansbriefing.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/372\/normal\/logo.png?1436525474"}},{"title":"April 2017 Briefing - Pathology","url":"http:\/\/ct.moreover.com\/?a=30419172435&p=1pl&v=1&x=Y7g6AYPwj5vxD_2HanTymg","license":"public","citation_ids":[19144044,19646721,19580227,19580227,19627670,19195540,19195540,19204132,19204132,19616324,15699050,15699050,19610886,16897001,16897001,19216712,19526108,19624230,19156636,19156636,19534209,19534209,19624032,19624032,19568825,19529354,18824778,19534436,19534436,19519363,19428209,19225181,19507617,19507617,19507612,19247043,19247043,19246823,19246823,13258253,13258253,19236749,19236749,18793597,19213405,18782529,18893596,18893596,18066954,18913241,18808817,18925116,18925116,18598364,13608988,13608988,15575500,18697241,18697241,18907478,18907478,18726006,18739492,18739492,18781728,18728884,18795005,18795005,18805190,18805190,18563201,18782645,18782990,18782787,18783142,18783142,12606060,12606060,18636402,18636402,18726682,15147774,15147774,18700687,15571369,15571369,18694823,18694823,18701309,16187189,19616400,19648879,19563228,19564504,19562266,19533256,19528789,19529821,19188403,19188665,17396516,17396516,19226926,19226926,18790877,18790877,18910266,18911974,18734267,14500434,14500434,19143442,19100751,19098774,18583923,18913723,18905418,18905418,18790932,18790932,18787032,18787032,18910931,18910931,18781970,18704994,18767470,18785543,18785543,18560451,18560451,18463319,18463319,18559756,18559756,18700922,18703038,18700688,18707125,18707125,13803683,13803683,18187123,19156355,19156355,19514068,19514068,19186270,19186270,19649261,19615060,19648961,19648961,19608589,17392296,17392296,18805231,19220683,18308598,18308598,18797489,19194695,19194695,18786735,19247081,18910288,18611771,18611771,19143414,19144461,19144795,19144795,18749754,18749754,18808466,18638272,18818003,18544190,18544190,18782997,18782997,18783030,18700622,18635362,18635362,18706952,18706061,13088643,13088643,18698953,18692314,18692314,19641829,19641829,19677020,19529278,19527347,19527347,18801752,19219468,19218686,19228057,19228057,18737015,18737015,18913467,18706260,18706261,18702517,18702517,18880713,18880713,18443914,18443914,17083152,17084663,18782856,18201429,18201429,18771105,18771105,18486060,18486060,17179960,17179960,18337870,18337870],"posted_on":"2017-05-01T15:21:35+00:00","summary":"Here are what the editors at HealthDay consider to be the most important developments in Pathology for April 2017.","author":{"name":"Physician's Briefing","url":"http:\/\/www.physiciansbriefing.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/372\/normal\/logo.png?1436525474"}},{"title":"April 2017 Briefing - Infectious Disease","url":"http:\/\/ct.moreover.com\/?a=30419709711&p=1pl&v=1&x=RZ_mLgPFHrroFDSdRVSsNw","license":"public","citation_ids":[19144044,19580227,19580227,19648961,19648961,19534209,19534209,19529354,19534436,19534436,19245742,19247043,19247043,19213405,19236749,19236749,18793597,18782529,19143414,18913241,18808817,18925116,18925116,13608988,13608988,15575500,18697241,18697241,18781728,15571369,15571369,18707125,18707125,16187189,16187189,16718686,16718686,12598989,12598989,18172634,18560353,18561179,18245236,18245236,18498537,18489263,18489263,18488940,18430287,18430287,18153746,18153746,18454694,18310218,18310218,16904190,18457075,19616400,19608589,19531389,17392296,17392296,19533256,19529821,19220683,19520547,19246823,19246823,18910288,19155198,19100751,19098774,18913723,18907478,18907478,18905418,18905418,18787032,18787032,18636402,18636402,18767470,18560451,18560451,18463319,18463319,18726682,17179960,17179960,18692314,18692314,18692467,18532902,18637388,18637388,18451011,18451011,18560410,18488225,18579462,18579462,18165074,18165074,18453096,18457397,19616049,19529278,19520073,18308598,18308598,19194695,19194695,18801752,19226926,19226926,18611771,18611771,18913467,19144795,19144795,18704812,18723533,17083152,17084663,18782856,18720198,18707635,12606060,12606060,18706952,18700687,16056297,16056297],"posted_on":"2017-05-01T16:23:02+00:00","summary":"Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for April 2017.","author":{"name":"Physician's Briefing","url":"http:\/\/www.physiciansbriefing.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/372\/normal\/logo.png?1436525474"}},{"title":"April 2017 Briefing - Pharmacy","url":"http:\/\/ct.moreover.com\/?a=30419912505&p=1pl&v=1&x=0P0gaVJ-QPi39pfSVygkmA","license":"public","citation_ids":[19156355,19156355,19514068,19514068,19186270,19186270,19649261,19195540,19195540,19204132,19204132,19615060,19648961,19648961,19608589,19624032,19624032,19216712,17392296,17392296,18805231,18824778,19529354,19220683,18308598,18308598,18797489,19194695,19194695,19247043,19247043,18786735,19247081,18910288,19226926,19226926,17396516,17396516,18611771,18611771,19143414,19143442,18925116,18925116,19100751,19098774,19144461,18913723,19144795,19144795,18739492,18739492,18749754,18749754,18910931,18910931,18808466,18638272,18818003,18544190,18544190,18782997,18782997,18783030,18563201,18767470,18700622,18560451,18560451,18635362,18635362,18706952,18706061,13088643,13088643,18698953,18707125,18707125,18692314,18692314,19144044,19646721,19616400,19648879,19563228,19564504,19562266,19568825,19533256,19528789,19529821,19188403,19188665,19236749,19236749,18793597,18066954,18790877,18790877,18910266,18911974,18734267,14500434,14500434,18913241,18808817,18583923,18598364,18907478,18907478,18905418,18905418,18697241,18697241,18790932,18790932,18787032,18787032,18728884,18781970,18795005,18795005,18704994,18805190,18805190,18782645,18782990,18782787,18783142,18783142,18636402,18636402,18785543,18785543,18463319,18463319,18726682,18559756,18559756,18700922,18703038,18700688,13803683,13803683,18187123,19580227,19580227,19627670,19616324,15699050,15699050,19610886,16897001,16897001,19526108,19624230,19156636,19156636,19534209,19534209,19534436,19534436,19519363,19428209,19225181,19507617,19507617,19507612,19246823,19246823,13258253,13258253,19213405,18782529,18893596,18893596,13608988,13608988,15575500,18726006,18781728,12606060,12606060,15147774,15147774,18700687,15571369,15571369,18694823,18694823,18701309,16187189,19641829,19641829,19677020,19529278,19527347,19527347,18801752,19219468,19218686,19228057,19228057,18737015,18737015,18913467,18706260,18706261,18702517,18702517,18880713,18880713,18443914,18443914,17083152,17084663,18782856,18201429,18201429,18771105,18771105,18486060,18486060,17179960,17179960,18337870,18337870],"posted_on":"2017-05-01T16:46:13+00:00","summary":"Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for April 2017.","author":{"name":"Physician's Briefing","url":"http:\/\/www.physiciansbriefing.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/372\/normal\/logo.png?1436525474"}},{"title":"April 2017 Briefing - Critical Care","url":"http:\/\/ct.moreover.com\/?a=30420081493&p=1pl&v=1&x=P0DqoVkKtgdxUH5Mehymxg","license":"public","citation_ids":[19144044,19641829,19641829,19677020,19648961,19648961,19531389,19624032,19624032,19568825,19534436,19534436,19247081,19247043,19247043,19194695,19194695,18801752,19226926,19226926,18913467,18925116,18925116,19144781,16135301,16135301,18697241,18697241,18704812,18723533,17083152,17084663,18818003,18720198,18707635,18705599,17408486,17408486,18337870,18337870,18707125,18707125,18692314,18692314,18692467,18245236,18245236,18430287,18430287,18488165,18310218,18310218,16904190,19580227,19580227,19534209,19534209,19529354,19245742,19213405,19236749,19236749,18793597,18782529,19143414,18913241,18808817,13608988,13608988,15575500,18781728,15571369,15571369,16187189,16187189,16718686,16718686,12598989,12598989,18172634,18560353,18561179,18498537,18489263,18489263,18488940,18153746,18153746,18454694,18457075,19616400,19608589,17392296,17392296,19533256,19529821,19220683,19520547,19246823,19246823,18910288,19155198,19100751,19098774,18913723,18907478,18907478,18905418,18905418,18787032,18787032,18636402,18636402,18767470,18560451,18560451,18463319,18463319,18726682,17179960,17179960,18532902,18637388,18637388,18451011,18451011,18560410,18488225,18579462,18579462,18165074,18165074,18453096,18457397,19648879,19195540,19195540,19204132,19204132,19228057,19228057,18910931,18910931,18294625,18691614,18691614,18726630,18727903,18771105,18771105,18595511,18532728,18532728,18007919,18007919,19616049,19529278,19520073,18308598,18308598,18611771,18611771,19144795,19144795,18782856,12606060,12606060,18706952,18700687,16056297,16056297],"posted_on":"2017-05-01T17:05:06+00:00","summary":"Here are what the editors at HealthDay consider to be the most important developments in Critical Care for April 2017.","author":{"name":"Physician's Briefing","url":"http:\/\/www.physiciansbriefing.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/372\/normal\/logo.png?1436525474"}},{"title":"April 2017 Briefing - Geriatrics","url":"http:\/\/ct.moreover.com\/?a=30419985098&p=1pl&v=1&x=A2cBEpjY9rUhqFFNUCLAxA","license":"public","citation_ids":[19144044,19641829,19641829,19677020,19648879,17392296,17392296,19568825,19529278,19533256,19528789,19529821,19527347,19527347,18824778,19534436,19534436,19519363,18308598,18308598,19220683,19246823,19246823,18801752,19219468,19218686,18910288,19226926,19226926,19228057,19228057,18611771,18611771,18737015,18737015,18910266,18911974,18913467,18706260,18706261,18925116,18925116,19143442,19144461,18702517,18702517,13608988,13608988,15575500,18697241,18697241,18880713,18880713,18910931,18910931,18749754,18749754,18443914,18443914,18795005,18795005,17083152,17084663,18563201,18782856,18767470,18782645,18782990,18782787,18636402,18636402,18463319,18463319,18201429,18201429,18771105,18771105,18726682,18486060,18486060,18559756,18559756,17179960,17179960,18337870,18337870,18707125,18707125,19646721,19616400,19563228,19564504,19562266,19188403,19188665,19236749,19236749,18793597,17396516,17396516,18066954,18790877,18790877,18734267,14500434,14500434,18913241,18808817,19100751,19098774,18583923,18913723,18598364,18907478,18907478,18905418,18905418,18790932,18790932,18787032,18787032,18728884,18781970,18704994,18805190,18805190,18783142,18783142,18785543,18785543,18560451,18560451,18700922,18703038,18700688,13803683,13803683,18187123,19156355,19156355,19514068,19514068,19186270,19186270,19649261,19195540,19195540,19204132,19204132,19615060,19648961,19648961,19608589,19624032,19624032,19216712,18805231,19529354,18797489,19194695,19194695,19247043,19247043,18786735,19247081,19143414,19144795,19144795,18739492,18739492,18808466,18638272,18818003,18544190,18544190,18782997,18782997,18783030,18700622,18635362,18635362,18706952,18706061,13088643,13088643,18698953,18692314,18692314,19580227,19580227,19627670,19616324,15699050,15699050,19610886,16897001,16897001,19526108,19624230,19156636,19156636,19534209,19534209,19428209,19225181,19507617,19507617,19507612,13258253,13258253,19213405,18782529,18893596,18893596,18726006,18781728,12606060,12606060,15147774,15147774,18700687,15571369,15571369,18694823,18694823,18701309,16187189],"posted_on":"2017-05-01T16:54:28+00:00","summary":"Here are what the editors at HealthDay consider to be the most important developments in Geriatrics for April 2017.","author":{"name":"Physician's Briefing","url":"http:\/\/www.physiciansbriefing.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/372\/normal\/logo.png?1436525474"}},{"title":"April 2017 Briefing - Pharmacy","url":"http:\/\/ct.moreover.com\/?a=30461479587&p=1pl&v=1&x=dcPWjh1sxAXce2fZG9bYZQ","license":"public","citation_ids":[19144044,19646721,19616400,19648879,19563228,19564504,19562266,19568825,19533256,19528789,19529821,19188403,19188665,19236749,19236749,18793597,17396516,17396516,19226926,19226926,18066954,18790877,18790877,18910266,18911974,18734267,14500434,14500434,18913241,18808817,19143442,18925116,18925116,19100751,19098774,18583923,18913723,18598364,18907478,18907478,18905418,18905418,18697241,18697241,18790932,18790932,18787032,18787032,18910931,18910931,18728884,18781970,18795005,18795005,18563201,18704994,18805190,18805190,18782645,18782990,18782787,18783142,18783142,18767470,18636402,18636402,18785543,18785543,18560451,18560451,18463319,18463319,18726682,18559756,18559756,18700922,18703038,18700688,18707125,18707125,13803683,13803683,18187123,19156355,19156355,19514068,19514068,19186270,19186270,19649261,19195540,19195540,19204132,19204132,19615060,19648961,19648961,19608589,19624032,19624032,19216712,17392296,17392296,18805231,18824778,19529354,19220683,18308598,18308598,18797489,19194695,19194695,19247043,19247043,18786735,19247081,18910288,18611771,18611771,19143414,19144461,19144795,19144795,18739492,18739492,18749754,18749754,18808466,18638272,18818003,18544190,18544190,18782997,18782997,18783030,18700622,18635362,18635362,18706952,18706061,13088643,13088643,18698953,18692314,18692314,19580227,19580227,19627670,19616324,15699050,15699050,19610886,16897001,16897001,19526108,19624230,19156636,19156636,19534209,19534209,19534436,19534436,19519363,19428209,19225181,19507617,19507617,19507612,19246823,19246823,13258253,13258253,19213405,18782529,18893596,18893596,13608988,13608988,15575500,18726006,18781728,12606060,12606060,15147774,15147774,18700687,15571369,15571369,18694823,18694823,18701309,16187189,19641829,19641829,19677020,19529278,19527347,19527347,18801752,19219468,19218686,19228057,19228057,18737015,18737015,18913467,18706260,18706261,18702517,18702517,18880713,18880713,18443914,18443914,17083152,17084663,18782856,18201429,18201429,18771105,18771105,18486060,18486060,17179960,17179960,18337870,18337870],"posted_on":"2017-05-05T04:09:29+00:00","summary":"Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for April 2017.","author":{"name":"Doctors Lounge","url":"http:\/\/www.doctorslounge.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/301\/normal\/Screen_Shot_2016-02-02_at_15.39.07.png?1454427565"}},{"title":"April 2017 Briefing - Urology","url":"http:\/\/ct.moreover.com\/?a=30419307459&p=1pl&v=1&x=13i60HXIh81ESt6x74cP_A","license":"public","citation_ids":[19144044,19568825,19519363,19507617,19507617,19507612,13258253,13258253,18910266,18911974,13608988,13608988,15575500,18702517,18702517,18697241,18697241,18910931,18910931,18691614,18691614,18443914,18443914,18805190,18805190,18767470,12606060,12606060,18560451,18560451,18201429,18201429,18559756,18559756,13088643,13088643,18707125,18707125,13803683,13803683,18560353,18245236,18245236,18533000,18533000,18489263,18489263,16904190,19580227,19580227,19648961,19648961,19534209,19534209,19529354,19534436,19534436,19245742,19247043,19247043,19213405,19236749,19236749,18793597,18782529,19143414,18913241,18808817,18925116,18925116,18781728,15571369,15571369,16187189,16187189,16718686,16718686,12598989,12598989,18172634,18561179,18498537,18488940,18430287,18430287,18153746,18153746,18454694,18310218,18310218,18457075],"posted_on":"2017-05-01T15:37:43+00:00","summary":"Here are what the editors at HealthDay consider to be the most important developments in Urology for April 2017.","author":{"name":"Physician's Briefing","url":"http:\/\/www.physiciansbriefing.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/372\/normal\/logo.png?1436525474"}},{"title":"HBV reactivation with direct acting antivirals for HCV is highly manageable","url":"http:\/\/ct.moreover.com\/?a=30570747060&p=1pl&v=1&x=Ncvtsgw6SZJ5-I5H0TAsZQ","license":"public","citation_ids":[19529354,19529354],"posted_on":"2017-05-15T07:17:07+00:00","summary":"Direct-acting antiviral agents (DAAs) are a safe and highly effective treatment for hepatitis C virus (HCV) infection and, with proper screening, monitoring and treatment, reactivation of hepatitis B virus (HBV) is a manageable adverse event\u2026","author":{"name":"Medical Economics ","url":"http:\/\/medicaleconomics.modernmedicine.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/531\/normal\/Screen_Shot_2016-01-06_at_16.09.09.png?1452096565"}}],"facebook":[{"title":"Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1318198384902630&id=247598615295951","license":"public","citation_ids":[19529354],"posted_on":"2017-04-25T19:20:05+00:00","summary":"Related Articles\n\nHepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System. \n\nAnn Intern Med. 2017 Apr 2","author":{"name":"Tom Heston MD","url":"https:\/\/www.facebook.com\/247598615295951","facebook_wall_name":"Tom Heston MD","image":"https:\/\/graph.facebook.com\/247598615295951\/picture","id_on_source":"247598615295951"}},{"title":"Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic HCV","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10154818129410910&id=341958175909","license":"public","citation_ids":[19529354],"posted_on":"2017-05-01T16:30:00+00:00","summary":"Use of direct-acting antivirals (DAAs) to treat patients with hepatitis C has become the standard of care. This report from the U.S. Food and Drug Administration focuses on an important safety concern when using DAAs in patients with HCV who are co-infecte","author":{"name":"Annals of Internal Medicine","url":"https:\/\/www.facebook.com\/341958175909","facebook_wall_name":"Annals of Internal Medicine","image":"https:\/\/graph.facebook.com\/341958175909\/picture","id_on_source":"341958175909"}},{"title":"Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1335030876534560&id=130767083627618","license":"public","citation_ids":[19529354],"posted_on":"2017-04-25T12:53:05+00:00","summary":"Related Articles\n\nHepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System. \n\nAnn Intern Med. 2017 Apr 2","author":{"name":"Internet Medical Association","url":"https:\/\/www.facebook.com\/130767083627618","facebook_wall_name":"Internet Medical Association","image":"https:\/\/graph.facebook.com\/130767083627618\/picture","id_on_source":"130767083627618"}},{"title":"Annals of Internal Medicine","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10154416218636471&id=139259651470","license":"public","citation_ids":[19529354],"posted_on":"2017-05-01T19:40:05+00:00","summary":"Use of direct-acting antivirals (DAAs) to treat patients with hepatitis C has become the standard of care. This report from the U.S. Food and Drug Administration focuses on an important safety concern when using DAAs in patients with HCV who are co-infecte","author":{"name":"Patient Care","url":"https:\/\/www.facebook.com\/139259651470","facebook_wall_name":"ConsultantLive","image":"https:\/\/graph.facebook.com\/139259651470\/picture","id_on_source":"139259651470"}},{"title":"HBV-R Associated With DAA Therapy for Chronic HCV | Annals of Internal Medicine | American College of Physicians","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1160980670673465&id=549025681868970","license":"public","citation_ids":[19529354],"posted_on":"2017-06-08T14:46:33+00:00","summary":"Nuevas drogas para hepatitis B, reactivadass por el tratamien con las nuevas drogas para hepatitics C. http:\/\/annals.org\/aim\/article\/2623165\/hepatitis-b-virus-reactivation-associated-direct-acting-antiviral-therapy-chronic","author":{"name":"CETSA - Isalud","url":"https:\/\/www.facebook.com\/549025681868970","facebook_wall_name":"CETSA - Isalud","image":"https:\/\/graph.facebook.com\/549025681868970\/picture","id_on_source":"549025681868970"}}]}}